GNLX Competitors & Alternatives
Compare Genelux Corporation Common Stock with similar stocks in the same industry
Biotechnology
GNLX
Main Stock$2.49
Tradestie Score
55
Market Cap
$166.20M
Revenue Growth
-1.0%
Analyst Upside
+663.1%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$23.99
|
$154.27M | - | 44 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$14.25
|
$133.50M | - | 41 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$19.00
|
$117.07M | - | 38 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.20
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
EUDA
EUDA Health Holdings Limited Ordinary Shares
|
$13.45
|
$73.94M | - | 50 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
More GNLX Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry